An open-label phase 2 study of bomedemstat, a lysine-specific demethylase 1 (LSD1) inhibitor, for the treatment of polycythemia vera

Publication

An open-label phase 2 study of bomedemstat, a lysine-specific demethylase 1 (LSD1) inhibitor, for the treatment of polycythemia vera

Rein, Lindsay
;
Livings, Alice
;
Innes, Andrew
;
Rinaldi, Ciro
;
Pettit, Kristen
;
Yeh, Paul
;
Larsen, Stephen
;
Watson, Anne-Marie
;
Leahy, Michael
;
Curto-Garcia, Natalia
... show 10 more

Glos Author

Frewin, Rebecca

Date

2024-06-14

Journal Title

Subject

Type

Conference Abstract

Engagement

Google Scholar:

Altmetric:

Collections

Show all metadata

Files

2024 Rein An open-label phase.pdf

Adobe PDF, 156.36 KB

Abstract

No abstract available

Citation

Rein et al (2024). An open-label phase 2 study of bomedemstat, a lysine-specific demethylase 1 (LSD1) inhibitor, for the treatment of polycythemia vera. HemaSphere. 8(Supplement 1), 5403-5404. https://doi.org/10.1002/hem3.104

DOI

10.1002/hem3.104

URI

https://hdl.handle.net/20.500.14709/1358

License

CC BY-NC-ND 4.0

Usage rights

CC BY-NC-ND 4.0

License

https://creativecommons.org/licenses/by-nc-nd/4.0/